How one innovator goes B2C to circumvent the payer reimbursement system w/ Jo Bhakdi

It’s taken a global pandemic to jumpstart the telehealth industry and showcase the value, convenience, and importance of bringing strong, viable, and scalable technology solutions to the market. And now that the spotlight’s been cast, there’s no going backwards. One might not think of disease detection and quantitative science as services that can be deployed via telehealth and a customer/member focused concierge solution, but Jo Bhakdi of Quantgene would argue that with you. His company built a product around advanced cancer detection using deep genomics and AI technologies and delivers that product in a package that bypasses the traditional healthcare payer system and offers a more affordable solution directly to the customer. And, when COVID-19 hit, Jo’s team was able to envision how a COVID-based solution could be offered to its members in a seamless pivot. In this episode, come hear Jo Bhakdi’s thoughts on the future of telehealth and concierge medicine, how to approach a successful market pivot, and the importance for health innovators to understand the “investor’s triangle” when bringing healthcare innovations to market.  Here are the show highlights: 5 crucial ingredients you must have to develop effective and disruptive healthcare technology (17:33)  This causes more healthcare innovations to die than anything else… (18:39)  The case for healthcare innovators to be ruthlessly selfish (20:05)  Why shrinking your addressable market can prevent your healthcare innovation from a premature death (25:24)  The “Investor’s Triangle” method for pitching investors that skyrockets your chances of getting investments (29:46)  Here’s how you can easily gain the upper hand when talking to potential investors (33:20)  Why you should celebrate the chaos of the current crisis (49:40)  I've spoken with dozens of health innovators, and nearly everyone is trying to figure out their best pivot strategy. But they don't know what to change, how to pivot, or if their new pivot strategy is the right move. So I went into overdrive putting together a clear, actionable 5-step worksheet that will help you quickly define your most viable and profitable pivot path through the COVID crisis. And I’m giving it to you for FREE — no strings attached at https://www.Legacy-DNA.com/Pivot Guest Bio Jo Bhakdi is the founder and CEO of Quantgene. Launched in 2015, Quantgene works on the theory that most diseases can be detected far earlier by employing quantitative science and a new level of precision into medical practice.  Jo holds a Masters in Economics and Psychology from Tubingen University, one of Germany’s leading academic institutions, with a focus on financial theory and statistics. Prior to Quantgene, Jo began his career at WPP and Omnicom, where he held Strategy and Executive Director positions. ‍If you’d like to learn more about Quantgene and the solutions Jo and his team have developed, you can reach out to him on Twitter at @jobhakdi, email at jb@quantgene.com, or on quantgene.com and chooseserenity.com.